Medicare Enrolled
Dr. Augustine Romano, M.D.
Neurology · Rocky Point, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Romano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Romano?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Romano
Dr. Augustine Romano is a neurology specialist in Rocky Point, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Romano performed 9,047 Medicare services across 804 unique beneficiaries.
Between the years covered by Open Payments, Dr. Romano received a total of $30,307 from 89 pharmaceutical and/or device companies across 1248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Romano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in NY
$30,307 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,047
Medicare services
Top 9% in NY for neurology
804
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~476 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
7,700 | $5 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $77 | $270 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
314 | $110 | $390 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
236 | $57 | $240 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
221 | $51 | $155 |
| New patient office visit, complex (60-74 min) | 117 | $194 | $750 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
39 | $92 | $455 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $153 | $525 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
26 | $189 | $825 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $78 | $250 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
12 | $166 | $695 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,307
Total received (2018-2024)
Avg $4,330/year across 7 years
Top 15% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
1,248
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,560 (74.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,748 (25.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,287
2023
$3,406
2022
$4,317
2021
$3,830
2020
$2,663
2019
$3,069
2018
$9,734
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$668
PFIZER INC.
$197
Novartis Pharmaceuticals Corporation
$189
Amneal Pharmaceuticals LLC
$189
Lundbeck LLC
$186
Teva Pharmaceuticals USA, Inc.
$181
Lilly USA, LLC
$156
ARGENX US, INC.
$137
Neurelis, Inc.
$118
Biogen, Inc.
$110
UCB, Inc.
$104
Neurocrine Biosciences, Inc.
$100
EMD Serono, Inc.
$95
Merz Pharmaceuticals, LLC
$88
SCILEX PHARMACEUTICALS INC.
$82
ACADIA Pharmaceuticals Inc
$77
Azurity Pharmaceuticals, Inc.
$66
MDD US Operations, LLC
$62
Axsome Therapeutics, Inc.
$58
Eisai Inc.
$53
SK Life Science, Inc.
$52
Kyowa Kirin, Inc.
$48
CSL Behring
$44
Grifols USA, LLC
$40
JAZZ PHARMACEUTICALS INC.
$37
Celgene Corporation
$31
Vanda Pharmaceuticals Inc.
$24
ITF Therapeutics LLC
$24
Alexion Pharmaceuticals, Inc.
$21
Acorda Therapeutics, Inc
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Otsuka America Pharmaceutical, Inc.
$16
Top 3 companies account for 32.1% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$7,554
UCB, Inc.
$1,606
ABBVIE INC.
$1,461
Biogen, Inc.
$1,438
Teva Pharmaceuticals USA, Inc.
$1,238
Amgen Inc.
$1,126
AbbVie Inc.
$1,116
Sunovion Pharmaceuticals Inc.
$1,069
Allergan, Inc.
$942
Lundbeck LLC
$905
Novartis Pharmaceuticals Corporation
$842
SK Life Science, Inc.
$832
Lilly USA, LLC
$647
Acorda Therapeutics, Inc
$583
Amneal Pharmaceuticals LLC
$555
PFIZER INC.
$497
Neurocrine Biosciences, Inc.
$411
EMD Serono, Inc.
$368
ACADIA Pharmaceuticals Inc
$352
Adamas Pharmaceuticals, Inc.
$328
Neurelis, Inc.
$325
Kyowa Kirin, Inc.
$307
ARBOR PHARMACEUTICALS, INC.
$303
Grifols USA, LLC
$294
UPSHER-SMITH LABORATORIES LLC
$260
Alexion Pharmaceuticals, Inc.
$253
Biohaven Pharmaceutical Holding Company Ltd.
$236
Biohaven Pharmaceuticals, Inc.
$204
ARGENX US, INC.
$190
GENZYME CORPORATION
$182
Eisai Inc.
$174
Allergan Inc.
$165
Almatica Pharma LLC
$162
Takeda Pharmaceuticals U.S.A., Inc.
$160
IDORSIA PHARMACEUTICALS US INC
$152
GE HEALTHCARE
$141
Assertio Therapeutics, Inc.
$139
Azurity Pharmaceuticals, Inc.
$129
Sumitomo Pharma America, Inc.
$128
Axsome Therapeutics, Inc.
$127
Medtronic, Inc.
$119
Avanir Pharmaceuticals, Inc.
$116
JAZZ PHARMACEUTICALS INC.
$110
SCILEX PHARMACEUTICALS INC.
$105
Upsher-Smith Laboratories LLC
$99
Genentech USA, Inc.
$88
Merz Pharmaceuticals, LLC
$88
CSL Behring
$83
EISAI INC.
$81
LivaNova USA, Inc.
$77
MDD US Operations, LLC
$77
Merz North America, Inc.
$74
Avion Pharmaceuticals
$73
Otsuka America Pharmaceutical, Inc.
$69
Celgene Corporation
$68
Abbott Laboratories
$66
Philips Electronics North America Corporation
$61
Greenwich Biosciences, Inc.
$60
Promius Pharma LLC
$60
E.R. Squibb & Sons, L.L.C.
$58
Bausch Health US, LLC
$52
Arbor Pharmaceuticals, Inc.
$49
Endo Pharmaceuticals Inc.
$48
Impax Laboratories, Inc.
$48
MITSUBISHI TANABE PHARMA AMERICA, INC.
$44
ASSERTIO THERAPEUTICS, Inc.
$44
BioDelivery Sciences International, Inc.
$43
Akcea Therapeutics, Inc.
$40
IMPEL PHARMACEUTICALS INC.
$32
Octapharma USA, Inc.
$32
MERZ NORTH AMERICA, INC.
$29
Mallinckrodt Hospital Products Inc.
$26
Vanda Pharmaceuticals Inc.
$24
ITF Therapeutics LLC
$24
Daiichi Sankyo Inc.
$22
Medtronic USA, Inc.
$20
US WorldMeds, LLC
$19
BANNER LIFE SCIENCES, LLC
$18
Currax Pharmaceuticals LLC
$18
Kowa Pharmaceuticals America, Inc.
$17
HARMONY BIOSCIENCES LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Scilex Pharmaceuticals Inc.
$17
Corium, LLC
$16
Horizon Therapeutics plc
$14
Egalet US Inc
$13
Vertical Pharmaceuticals, LLC
$12
Collegium Pharmaceutical, Inc.
$10
Neuronetics, Inc.
$10
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Azstarys · BAFIERTAM · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Betaseron · Briviact · CAMBIA · CITALOPRAM · COMIRNATY · CONTRAVE · CREXONT · Cambia · Confirm Rx · DIVIGEL · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · Kcentra · LINZESS · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Morphabond ER · NAPRELAN · NASCOBAL · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Respiratoriy Care Undiv · Rystiggo · SOLIRIS · SPRIX · Seglentis · Soliris · Sunosi · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · Wellcentive Undiv · XCOPRI · XEOMIN · XYWAV · Xadago · Xembify · Xeomin · Xtampza ER · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
213
Per 100K population
14.0
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Romano is a mixed practice specialist, with above-average Medicare volume (top 9% in NY), with low-engagement industry engagement in the top 15% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Romano experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Romano performed 7,700 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Romano receive payments from pharmaceutical companies?
Yes. Dr. Romano received a total of $30,307 from 89 companies across 1,248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Romano's costs compare to other neurologists in Rocky Point?
Dr. Romano's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Romano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rocky Point
Browse neurologists in Rocky Point ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology